Trademarks = 2

Forward Citations = 131

Loading Chart...

1 inventor (with patents filed for the assignee):

David W Osborne (6 out of 43 patents)

6 patents: Sort by Forward Citations

1. 10940142 - Inhibition of crystal growth of roflumilast (2021-03-09),

2. 10172841 - Inhibition of crystal growth of roflumilast (2019-01-08),

3. 10105354 - Inhibition of crystal growth of roflumilast (2018-10-23),

4. 9907788 - Inhibition of crystal growth of roflumilast (2018-03-06),

5. 9895359 - Inhibition of crystal growth of roflumilast (2018-02-20),

6. 9884050 - Inhibition of crystal growth of roflumilast (2018-02-06),

Arcutis, Inc. is a biopharmaceutical company focused on developing innovative therapies for dermatological conditions. With a pipeline of potential treatments for psoriasis, eczema, and other skin diseases, Arcutis is committed to improving the lives of patients with chronic skin conditions.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

6 Patents

#193 in Menlo Park, CA

#10,565 in California

#44,949 in US

Menlo Park, CA, United States of America

Arcutis, Inc.

Forward Citations = 131

1 inventor:

David W Osborne (6 out of 43 patents)

Please report any incorrect information to [email protected]